White matter disease: Targeted aspartoacylase gene therapy reverts Canavan disease – Nature.com
Nature.comWhite matter disease: Targeted aspartoacylase gene therapy reverts Canavan diseaseNature.comOn the basis of these findings, the researchers designed a gene therapy approach to specifically deliver functional ASPA to oligodendrocytes. “Our app… Continue reading
